Abstract
Background: Since ancient times, the use of cannabis as a medicine is well documented due to its potential therapeutic activity while subsequently its use as drug of abuse spread increasingly.
Objective: The present review sought to give an insight in the history of medical and recreational use of cannabis in India. Conclusion: Indian use of cannabis dates back to Vedic time, mostly for the ritualistic and religious purposes, as documented in the ancient literature. It was India that introduced the medical use of cannabis to neighboring countries. Nevertheless, in the same India, medical use did not propagate due to religious and social stigma related to the plant itself. The pharmacoactive constituents of cannabis and their therapeutic values in Ayurvetic medicine have been here described together with the adverse effects they can cause with special reference to neurological ones, including withdrawal symptoms. Finally, how cannabis made its route to the Indian society has also been discussed.Keywords: Cannabis, medical use, therapeutic use, neurological effect, abuse, medicine.
CNS & Neurological Disorders - Drug Targets
Title:Cannabis: A Neurological Remedy or a Drug of Abuse in India
Volume: 16 Issue: 5
Author(s): Pronit Biswas*, Pooja Mishra, Devasish Bose and Abhilasha Durgbanshi*
Affiliation:
- Department of Criminology and Forensic Science, Dr. Harisingh Gour University, Sagar,India
- Departments of Chemistry, Dr. Harisingh Gour University, Sagar,India
Keywords: Cannabis, medical use, therapeutic use, neurological effect, abuse, medicine.
Abstract: Background: Since ancient times, the use of cannabis as a medicine is well documented due to its potential therapeutic activity while subsequently its use as drug of abuse spread increasingly.
Objective: The present review sought to give an insight in the history of medical and recreational use of cannabis in India. Conclusion: Indian use of cannabis dates back to Vedic time, mostly for the ritualistic and religious purposes, as documented in the ancient literature. It was India that introduced the medical use of cannabis to neighboring countries. Nevertheless, in the same India, medical use did not propagate due to religious and social stigma related to the plant itself. The pharmacoactive constituents of cannabis and their therapeutic values in Ayurvetic medicine have been here described together with the adverse effects they can cause with special reference to neurological ones, including withdrawal symptoms. Finally, how cannabis made its route to the Indian society has also been discussed.Export Options
About this article
Cite this article as:
Biswas Pronit *, Mishra Pooja, Bose Devasish and Durgbanshi Abhilasha*, Cannabis: A Neurological Remedy or a Drug of Abuse in India, CNS & Neurological Disorders - Drug Targets 2017; 16 (5) . https://dx.doi.org/10.2174/1871527316666170424115008
DOI https://dx.doi.org/10.2174/1871527316666170424115008 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Do Geriatric Outpatients Adhere to Medication Changes Advised After Assessment? An Exploratory Pilot Study
Current Clinical Pharmacology Pharmacological Treatments for Cocaine Dependence: Is There Something New?
Current Pharmaceutical Design Actionable Nutrigenetics for Genetically Based Diseases? A New Critical Path to P4 Medicine
Current Pharmacogenomics and Personalized Medicine Acetylcholinesterase Inhibitors as a Starting Point Towards Improved Alzheimers Disease Therapeutics
Current Pharmaceutical Design Is Time to Change to Halogenated Drugs in Cardiac Surgery, What do we have to do with Propofol?
Current Pharmaceutical Design ACKNOWLEDGEMENTS TO REVIEWERS
Central Nervous System Agents in Medicinal Chemistry A Review of Eugenol-based Nanomedicine: Recent Advancements
Current Bioactive Compounds The Pathogenic Subpopulation of Th17 Cells in Obesity
Current Pharmaceutical Design Transseptal Access to the Left Atrium: Tips and Tricks to Keep it Safe Derived from Single Operator Experience and Review of the Literature
Current Cardiology Reviews Ginkgo biloba Extract EGb761 Attenuates Hyperhomocysteinemia-induced AD Like Tau Hyperphosphorylation and Cognitive Impairment in Rats
Current Alzheimer Research Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 Alpha: An Emerging Target for Neuroprotection in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Protein Glycation: An Old Villain is Shedding Secrets
Combinatorial Chemistry & High Throughput Screening The Target of Regulating The ATP-binding Cassette A1 Protein (ABCA1): Promoting ABCA1-Mediated Cholesterol Efflux in Different Cells
Current Pharmaceutical Biotechnology Is there a Possible Single Mediator in Modulating Neuroendocrine–thymus Interaction in Ageing?
Current Aging Science The Aromatic Stacking Interactions Between Proteins and their Macromolecular Ligands
Current Protein & Peptide Science Recent Developments in Nucleophilic Radical Addition to Imines: the Key Role of Transition Metals and the New Porta Radical-Type Version of the Mannich and Strecker Reactions
Mini-Reviews in Organic Chemistry Intravesical Botox for Overactive Bladder: How to Minimize Complications and Manage Failures
Current Drug Targets Review of Evidence and Perspectives of Flavonoids on Metabolic Syndrome and Neurodegenerative Disease
Protein & Peptide Letters Cyclooxygenase-2 Biology
Current Pharmaceutical Design Expression, Purification and In Silico Studies of Cold Resistant Protein from Plant Growth Promoting Ps fluorescens Mutant CRPF1
Current Biotechnology